Literature DB >> 8538573

Superantigens and pseudosuperantigens of gram-positive cocci.

B Fleischer1, D Gerlach, A Fuhrmann, K H Schmidt.   

Abstract

Superantigens use an elaborate and unique mechanism of T lymphocyte stimulation. Prototype superantigen are the pyrogenic exotoxins produced by Staphylococcus aureus and Streptococcus pyogenes. Many candidate proteins of bacterial, viral and protozoal origin have recently been reported to be superantigens. In most cases the evidence that these proteins are in fact superantigens is highly indirect. In this review the evidence that gram-positive cocci produce superantigens other than the pyrogenic exotoxins is critically discussed. Evidence in described demonstrating that the epidermolytic toxins of Staphylococcus aureus and the pyrogenic exotoxin B and M-proteins of Streptococcus pyrogenes are not superantigens. Criteria are described for acceptance of a candidate as a superantigen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8538573     DOI: 10.1007/bf00216783

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  81 in total

1.  The role of the serine protease active site in the mode of action of epidermolytic toxin of Staphylococcus aureus.

Authors:  M B Redpath; T J Foster; C J Bailey
Journal:  FEMS Microbiol Lett       Date:  1991-06-15       Impact factor: 2.742

2.  Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.

Authors:  R D Horstmann; H J Sievertsen; J Knobloch; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  Multiple binding of type 3 streptococcal M protein to human fibrinogen, albumin and fibronectin.

Authors:  K H Schmidt; K Mann; J Cooney; W Köhler
Journal:  FEMS Immunol Med Microbiol       Date:  1993-08

4.  Separation of mitogenic and pyrogenic activities from so-called erythrogenic toxin type B (Streptococcal proteinase).

Authors:  D Gerlach; W Reichardt; B Fleischer; K H Schmidt
Journal:  Zentralbl Bakteriol       Date:  1994-03

5.  Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigen.

Authors:  B Fleischer; C J Bailey
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

6.  Evidence for superantigen production by Yersinia pseudotuberculosis.

Authors:  J Abe; T Takeda; Y Watanabe; H Nakao; N Kobayashi; D Y Leung; T Kohsaka
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

7.  Random depletion of T cells that bear specific T cell receptor V beta sequences in AIDS patients.

Authors:  D M Boldt-Houle; C R Rinaldo; G D Ehrlich
Journal:  J Leukoc Biol       Date:  1993-11       Impact factor: 4.962

Review 8.  The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions.

Authors:  P Marrack; G M Winslow; Y Choi; M Scherer; A Pullen; J White; J W Kappler
Journal:  Immunol Rev       Date:  1993-02       Impact factor: 12.988

9.  Superantigenicity of streptococcal M protein.

Authors:  M Tomai; M Kotb; G Majumdar; E H Beachey
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

10.  Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell receptor V beta 5-bearing CD8+ lymphocytes.

Authors:  E Y Denkers; P Caspar; A Sher
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  7 in total

1.  Structural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-IIalpha.

Authors:  Heike I Krupka; Brent W Segelke; Robert G Ulrich; Sabine Ringhofer; Mark Knapp; Bernhard Rupp
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

2.  Interleukin-12 alone can not enhance the expression of the cutaneous lymphocyte associated antigen (CLA) by superantigen-stimulated T lymphocytes.

Authors:  H Sigmundsdóttir; J E Gudjónsson; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

Review 3.  Common themes in microbial pathogenicity revisited.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

4.  B cell superantigens in the human intestinal microbiota.

Authors:  Jeffrey J Bunker; Christoph Drees; Andrea R Watson; Catherine H Plunkett; Cathryn R Nagler; Olaf Schneewind; A Murat Eren; Albert Bendelac
Journal:  Sci Transl Med       Date:  2019-08-28       Impact factor: 17.956

Review 5.  Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome.

Authors:  S Ladhani; C L Joannou; D P Lochrie; R W Evans; S M Poston
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

6.  Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin B.

Authors:  Chad J Roy; Kelly L Warfield; Brent C Welcher; Raoul F Gonzales; Tom Larsen; Julie Hanson; Chella S David; Theresa Krakauer; Sina Bavari
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

7.  Exclusion of bioactive contaminations in Streptococcus pyogenes erythrogenic toxin A preparations by recombinant expression in Escherichia coli.

Authors:  U Fagin; U Hahn; J Grötzinger; B Fleischer; D Gerlach; F Buck; A Wollmer; H Kirchner; L Rink
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.